Feng Ming Liu
Vorstandsvorsitzender bei Changzhou Biowin Pharmaceutical Co., Ltd.
Profil
Feng Ming Liu is currently the Chairman & General Manager at Changzhou Biowin Pharmaceutical Co., Ltd.
Previously, he worked as the Chief Executive Officer & Chief Scientist at Shineco, Inc. Liu holds a doctorate degree from Peking Union Medical College.
Aktive Positionen von Feng Ming Liu
| Unternehmen | Position | Beginn |
|---|---|---|
Changzhou Biowin Pharmaceutical Co., Ltd.
 Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China. | Vorstandsvorsitzender | 01.01.2012 |
Ehemalige bekannte Positionen von Feng Ming Liu
| Unternehmen | Position | Ende |
|---|---|---|
| SHINECO, INC. | Vorstandsvorsitzender | - |
Ausbildung von Feng Ming Liu
| Peking Union Medical College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SHINECO, INC. | Process Industries |
| Private Unternehmen | 1 |
|---|---|
Changzhou Biowin Pharmaceutical Co., Ltd.
Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China. | Health Technology |
